The Science
Autoimmune conditions arise when inflammation spreads throughout the body. Overactive immune signals, stressed mitochondria, and disrupted energy metabolism combine to drive fatigue, tissue damage, and faster aging. Restoring immune balance and cellular energy can calm inflammation, protect organs, and improve overall health and performance.
Cellular drivers of autoimmune decline and longevity

Interventions can help
Restoring Mitochondrial Health
Mitochondrial support from methylene blue, AMPK activators, and urolithin A boosts energy production and reduces oxidative stress. Restoring mitochondrial function helps ease fatigue, brain fog, and muscle weakness in autoimmune and post-viral syndromes.



Recalibrate Immune Responses
Targeted therapies such as rapamycin and LDN help quiet overactive immune pathways while strengthening regulatory mechanisms. By restoring balance, these interventions reduce tissue-damaging responses that fuel autoimmune conditions.
Resolve Chronic Inflammation
Persistent low-grade inflammation, driven by senescent cells and impaired autophagy, accelerates tissue breakdown. Rapamycin, LDN, and AMPK activators reduce inflammation, enhance clearance, and protect organ health.

Recalibrate Immune Responses
Targeted therapies such as rapamycin and LDN help quiet overactive immune pathways while strengthening regulatory mechanisms. By restoring balance, these interventions reduce tissue-damaging responses that fuel autoimmune conditions.

Restoring Mitochondrial Health
Mitochondrial support from methylene blue, AMPK activators, and urolithin A boosts energy production and reduces oxidative stress. Restoring mitochondrial function helps ease fatigue, brain fog, and muscle weakness in autoimmune and post-viral syndromes.

Resolve Chronic Inflammation
Persistent low-grade inflammation, driven by senescent cells and impaired autophagy, accelerates tissue breakdown. Rapamycin, LDN, and AMPK activators reduce inflammation, enhance clearance, and protect organ health.
Hear from our patients
(Featured In)
(Featured In)
Ahead of the field
“I would say that rapamycin is the current best-in-class for a longevity drug”
“Rapamycin... is at the leading edge of a generation of research trials.”
“I would say that rapamycin is the current best-in-class for a longevity drug”
“Rapamycin... is at the leading edge of a generation of research trials.”
“I would say that rapamycin is the current best-in-class for a longevity drug”
“Rapamycin... is at the leading edge of a generation of research trials.”
“I would say that rapamycin is the current best-in-class for a longevity drug”
“Rapamycin... is at the leading edge of a generation of research trials.”
We study the studies
Healthspan longevity experts continuously review the latest clinical research, curating results to help deepen your understanding of aging science.